Other Common Ingredients: Weak Evidence, Strong Marketing Several other compounds appear regularly in GLP-1 supplement formulations, typically with minimal evidence for the specific claims made: Chromium Picolinate Marketed for insulin sensitivity and glucose metabolism, chromium shows weak and inconsistent evidence
Tirzepatide, with its dual-action, targets both the GLP-1 and GIP receptors, offering additional benefits for weight loss and blood sugar control
If I can do it, so can you. Ready to create your own success story
Stop using Rybelsus and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat
Across the treatment arms, the mean age of patients was 56 years, 3.4% were 75 years or older and 55% were male